Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Joe Ordia

Neurological Surgery Peabody, MA Medical Doctor

NPI 1770522864 CMS profile 352946

10 Centennial Dr, East Entrance, Peabody, MA 01960

Open in the dashboard

General payments

$3,106

23 records reported · program years 2019–2024

Research payments

$7,013

Paid to them · 4 records reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Joe Ordia of Peabody, MA is reported in the CMS Open Payments database as having received $3,106 across 23 general payments and $7,013 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 70th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2024 Research $3,825 2
2023 General $25 1
2023 Research $3,188 2
2022 General $26 1
2021 General $21 1
2020 General $2,869 11
2019 General $164 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joe Ordia
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Joe Ordia were reported at $0. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Joe Ordia Neurological Surgery median Middle half National median
2019 $164 $582 $138–$3,006 $163
2020 $2,869 $294 $76–$2,174 $114
2021 $21 $387 $105–$2,432 $132
2022 $26 $542 $139–$2,989 $149
2023 $25 $534 $145–$2,697 $160
2024 $0 $574 $155–$3,046 $164
2025 $0 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Intrinsic Therapeutics $2,700 9 payments
  2. SPR Therapeutics, Inc $149 1 payment
  3. Medtronic, Inc. $73 3 payments
  4. SI-BONE, Inc. $39 3 payments
  5. Medtronic USA, Inc. $39 2 payments
  6. TerSera Therapeutics LLC $37 2 payments
  7. Amgen Inc. $31 1 payment
  8. Nevro Corp. $21 1 payment
  9. Allergan Inc. $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $2,700 9 payments
  2. Food and Beverage $406 14 payments
Products named General payments · program years 2019–2024
  1. Barricaid Annular Closure Device $2,700 9 payments
  2. SPRINT PNS System $149 1 payment
  3. INTELLIS ADAPTIVESTIM $52 2 payments
  4. IFUSE IMPLANT $39 3 payments
  5. PRIALT $37 2 payments
  6. AIMOVIG $31 1 payment
  7. SYNCHROMED $21 1 payment
  8. Senza Spinal Cord Stimulation System $21 1 payment
  9. INTELLIS $20 1 payment
  10. MYSTIM $19 1 payment
  11. Other $17 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Intrinsic Therapeutics $7,013 4 payments

Records

27 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record